Tesamorelin sits on the WADA 2026 Prohibited List under section S2.2.4 (Growth Hormone Releasing Factors), named alongside CJC-1293, CJC-1295, and Sermorelin in the GHRH analogue subgroup
GLP-1 medicines in pregnancy is contraindicated and should be discontinued at least 2 months before a planned pregnancy
es mejor para la recuperacin para apoyar el entrenamiento constante, que impulsa el crecimiento muscular con el tiempo
A small colony that would have been suppressed by the combination of benzyl alcohol and cold can now flourish
Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, Zhang R, Su T, Ma X, Zeng C, Wang H, Ren J, Cao F: Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism